Andere Kunden interessierten sich auch für
![HELPING YOU DO RESEARCH IN THE EARLY STAGES]( "HELPING YOU DO RESEARCH IN THE EARLY STAGES")
HELPING YOU DO RESEARCH IN THE EARLY STAGES48,99 €![How the Stages of Deployment Impact Family Dynamics]( "How the Stages of Deployment Impact Family Dynamics")
How the Stages of Deployment Impact Family Dynamics28,99 €![A Psychological Treatment to Facilitate Recovery in Early Psychosis]( "A Psychological Treatment to Facilitate Recovery in Early Psychosis")
A Psychological Treatment to Facilitate Recovery in Early Psychosis35,99 €![The Psychological Treatment of Couples Confronting Breast Cancer]( "The Psychological Treatment of Couples Confronting Breast Cancer")
The Psychological Treatment of Couples Confronting Breast Cancer48,99 €![Diagnosis code F32.2]( "Diagnosis code F32.2")
Diagnosis code F32.215,99 €![Kohlberg's Stages of Moral Development]( "Kohlberg's Stages of Moral Development")
Kohlberg's Stages of Moral Development28,99 €![The American Experience with Alcohol]( "The American Experience with Alcohol")
The American Experience with Alcohol83,99 €
There is an abundance of research on the
psychopharmacological treatment of depression.
However, recent controversy surrounding potential
increases in suicidality with SSRIs has highlighted
deficits in our understanding of experience during
treatment. To explore the nature of changes in inner
experience during the initiation of medication, we
recruited three depressed individuals. We conducted
in-depth case studies of their experience over the
first 10 weeks of medication. Participants completed
weekly questionnaires and participated in Descriptive
Experience Sampling (DES). The profiles of these
three participants varied greatly. The participants
showed high degrees of comorbidity and different
patterns of changes in symptoms over the 10 weeks.
Interestingly, none of the participants reported
depression in their momentary experience after the
first week. These three case studies support careful
exploration of the inner experience of individuals
initiating treatment with antidepressant medication.
They also point to the potential value of taking an
idiographic approach, which recognizes the unique
inner experience of individuals, before attempting to
draw generalizations.
psychopharmacological treatment of depression.
However, recent controversy surrounding potential
increases in suicidality with SSRIs has highlighted
deficits in our understanding of experience during
treatment. To explore the nature of changes in inner
experience during the initiation of medication, we
recruited three depressed individuals. We conducted
in-depth case studies of their experience over the
first 10 weeks of medication. Participants completed
weekly questionnaires and participated in Descriptive
Experience Sampling (DES). The profiles of these
three participants varied greatly. The participants
showed high degrees of comorbidity and different
patterns of changes in symptoms over the 10 weeks.
Interestingly, none of the participants reported
depression in their momentary experience after the
first week. These three case studies support careful
exploration of the inner experience of individuals
initiating treatment with antidepressant medication.
They also point to the potential value of taking an
idiographic approach, which recognizes the unique
inner experience of individuals, before attempting to
draw generalizations.